As the Managing Partner at Aquillius Ventures, I oversee the investment strategy, portfolio management, and deal sourcing of a leading VC firm that focuses on early-stage startups in the biotech, medtech and agtech sectors. I also serve as the Vice President at the Aquillius Innovation Hub, where I manage the operations, financial planning, and business development of the firm. Additionally, I am a board member of Microtek, Inc., a microelectronic manufacturing company that provides innovative solutions for the medtech industry. I hold an MBA in Finance from the University of Colorado Denver and a certificate from VC University, where I learned the latest trends and best practices in the VC field. I am proficient in investment analysis, data analysis, and SWOT analysis, and I have a passion for finding and supporting disruptive and scalable businesses that can make a positive impact on the world. I value collaboration, diversity, innovation, and social responsibility, and I seek to work with like-minded entrepreneurs, investors, and partners.

Eric C. Ulchaker brings over a decade of entrepreneurial experience, including more than two years in venture capital, with a proven track record of successful ventures. He previously served as Fund Manager for the Pit Road Fund, a $23 million pre-seed and seed-stage venture fund affiliated with the University of Notre Dame, and played a key role in raising the 1842 Fund – a partnership between High Alpha Innovation and the University of Notre Dame – where he led diligence efforts following the fund’s initial $17.5 million close. Eric is currently a Managing Partner at Serial Stage Venture Partners (SSVP), a Cleveland-based, healthcare-focused investor network with over 150 members. He is also an active angel investor. Passionate about MedTech, BioTech, and HealthTech, Eric has supported startups such as Pulmonary Apps, Apportis, and Million Marker, a Y Combinator-backed company.

Ralph Morales III is an accomplished leader in the wearables and health tech space, with over 15 years of experience driving innovation and market growth. He has held pivotal roles at companies like Oura, where he led the development of healthcare solutions that generated significant revenue and expanded digital health capabilities. Ralph is a solution advocate for integrating digital biomarkers and real-time health insights to improve therapeutic outcomes and advance health span.  

‍

Anshuman Sharma, brings over 20 years of operator and investor experience. He started his career in R&D at Medtronic commercializing best-in-class implantable devices, including the very first DBS device. His operator experience spans early stage startups across med devices and digital health. Having been part of five founding teams, with three exits (Klio, Gecko, and iVizz) he has successfully raised multiple rounds of capital for early stage ventures from angels, UHNI, and institutional VC. As an investor he's part of CVC(BestBuy), angel/syndicate and institutional venture capital firms (MBx and Vectors). In addition to that he has held senior leadership roles at Transoma Medical, Biofourmis and at the CMS. He has an MPH from Harvard, MSEE from UC Berkeley and BSEE from Georgia Tech.

Greg is an AI venture studio thought leader, entrepreneur, and international networker, bringing entrepreneurs, executives and investors together from across the globe. He is a founder and partner of ScaleUp Labs, a pioneering applied AI venture studio and international accelerator. Greg is an early-stage technology startup founder, investor, advisor and operator, with a focus on digital health and international startups. Greg has been engaged in the US and international startup ecosystems for many years. In addition to his role at ScaleUp Labs, Greg has co-founded several other initiatives aimed at fostering startup ecosystems globally. He is a Co-Founder and Partner at AccelHUB Venture Partners, a company that supports the scaling of international technology startups. He also co-founded ScaleUp LatAm, an organization focused on promoting entrepreneurship in Latin America, and Accelerate Italy, which aims to boost Italian startups.

Ameen Shallal is the Head of Placement at EGIS Careers, a multi-service recruiting agency that connects early-career talent to internships and experienced candidates into full-time roles in high finance and consulting while providing coaching and mentorship to help them grow into the next generation of industry leaders. Over the last 15 years, Ameen has placed over 5,000 professionals in internships and full-time positions in industries such as venture capital, investment banking, private equity and management consulting across the United States.

Kathleen Snyder is a senior counsel at Husch Blackwell where she runs the firm’s AI in Healthcare Working Group. Based in Boston, Kathleen practices at the intersection of healthcare and technology, providing clients with practical legal advice on AI Governance, strategic technology and commercial contracts, data strategies, intellectual property, and regulatory interpretation. With 20+ years of experience in the healthcare industry, Kathleen has an intrinsic understanding of the healthcare landscape. Her technology-focused transactional practice, coupled with her regulatory experience, gives her a unique perspective that allows her to provide holistic legal advice to clients.

Arlene has practiced public accounting since 1993 and is a member of the firm’s Technology, Communications & Media, and Life Sciences Practice. She primarily works with biotechnology, pharmaceutical drug discovery, medical devices, and laboratory testing companies. Arlene consults clients in the application and implementation of new accounting policies and technical guidance in compliance with SEC, SOX 404, and US GAAP requirements. In addition, she has led numerous initial and subsequent public offerings and merger and acquisition activities including due diligence, and related accounting and SEC reporting.

Andrew Robbie is Enlil’s US-East Sales Executive, where he partners with early-stage MedTech companies to accelerate innovation while navigating regulatory complexity. With over two decades of experience in enterprise software and digital transformation, Andrew brings a unique blend of commercial, technical, and strategic expertise. Prior to Enlil, he spent over ten years at Dassault Systèmes in roles spanning medical device solutions strategy, diagnostics sales, and global client engagement. He played a critical role in expanding market share and supporting strategic initiatives including cloud transformation across North America and Europe.

Jennifer Burdman is Managing Director at Sauvegarder Investment Management (SIM IP), where she leads strategy and execution for intellectual property-based financing, investment, and monetization opportunities. She is an IP strategist and former executive at biotechnology companies and previously a partner in an international law firm. As the former Chief Intellectual Property Officer at a number of biotech startups, she has developed and implemented company IP strategy and counseled executive management and boards of directors on matters relating to the acquisition, protection, licensing, and enforcement of IP rights. Jennifer has been a first-chair trial lawyer in complex, high-stakes litigation in patent infringement, trade secret misappropriation, and disputes involving IP.

Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

Sarah has practiced public accounting since 1999 primarily serving early-stage clients in the life sciences industry, including biotechnology, diagnostics and medical device companies. Her expertise also includes working with venture funds focusing on investment valuation and other complex accounting issues. She consults clients in the application and implementation of new accounting policies and technical guidance. In addition, she has led numerous initial public offerings and merger and acquisition activities including due diligence and related accounting and SEC reporting.

Mindy Berman brings over 25 years of strategic management experience to IGS, which she founded in 1998. Her leadership on strategy reviews, industry assessments, and due diligence studies enables clients to gain a comprehensive view of the marketplace and the foresight to make critical business decisions, particularly around acquisitions and investments. She has extensive experience helping clients develop smart strategic plans – enabling them to enhance growth and profitability.

Max is a strategic advisor to life sciences innovators, helping pharma, biotech, and medtech companies to navigate the global payer and policy landscape and enable their innovations reach patients around the world. His experience spans all stages of product development and a wide range of therapeutic areas, including oncology, inflammatory conditions, rare diseases and cell and gene therapies. Max is a Partner in Trinity's Evidence, Value, Access, and Pricing practice and the Co-Founder of SVRN, the Scientific Value Return Network.

Eli co-founded Ontologic, Aquillius' partner in building the Digital Lab, after completing a PhD in computational neuroscience at MIT. He currently lives in the Boston area, and enjoys connecting with other startup founders.